Table 4 Performances of radiomic, clinical and pathologic tumor-node-metastasis signatures

Prospective

(n = 108)

Rad

0.62 (IQR 0.58–0.64)

2.12 (CI 1.04–4.47)

0.05

cTNM

0.55 (IQR 0.54–0.56)

1.67 (CI 0.65–4.27)

0.40

Prospective subset 1

(n = 75)

Rad

0.62 (IQR 0.58–0.65)

2.49 (CI 1.18–5.25)

0.03

cTNM

0.54 (IQR 0.52–0.55)

1.47 (CI 0.53–4.04)

0.63

pTNM

0.56 (IQR 0.53–0.61)

1.40 (CI 0.49–3.91)

0.72